The findings of a trial presented at the European Association for the Study of Diabetes found promising results in regards to treating hypoglycemia through the nose. As strange as it sounds, it could ...

Vergult et al 1 present interesting and useful descriptions of three patients with deletions at 12q15. It would be helpful if they could clarify one point, however. The authors refer throughout the ...

Lilly has bought itself worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycaemia in people with diabetes treated with insulin, for an undisclosed amount. Lilly ...